Specific Systems of Treatment
For thousands of years, natives have used urine to treat disease. In the early 1950s, Dr. Danopou- los, a Greek physician, found that it had anti-can- cer properties. Trying to isolate the specific factor which was the active agent, he found it was urea.
L.A. ERF, M.D., and B.J. MILLER, M.D., 1957
Urea is the end product of protein metabo- lism and is the primary substance excreted in urine.
Of course, all the urine research carried on by Danopoulos and others used purified, steril- ized extracts; they did not use raw urine. Urea is not urine.
Danopoulos injected 2-3 ml of a 50-percent urea solution directly into the mass of a fast-grow- ing tumor, which showed good results. But he found that he did better by injecting the urea very close to the tumor.
The urea must be injected into and close to the tumor itself.
A research study in India reported as much as 75% reduction in inoperable cancer of the uterine cervix by means of injections of 40% urea solu- tion directly into the tumor, along with a localized application of a 50% urea ointment (G.M. Gandhi, et. al, “Urea in the Management of Advanced Ma- lignancies,” Journal of Surgical Oncology, 9:139- 46, 1977).
In the case of liver cancer, urea is best taken orally. It reaches the liver directly from the intes- tines via the portal vein in a high enough concen- tration to be of significant value.
The outer surface of tumor cells have a spe- cial type of chemical which enables them to more easily enlarge and bond with other cells. The re- sult is a structured water matrix surrounding can- cer cells, which enables them to crowd together and excrete and absorb chemicals in abnormal ways.
University of Illinois Medical Center research- ers found that urea injections disrupt this water matrix, and interferes with the processes needed for continued uncontrolled cellular growth (Clinical Oncology, 3:319-320, 1977). They dis- rupted it with a 40% urea solution, injected di- rectly into the tumor mass and into the area sur- rounding it.
The normal injection dosage varies from 10% to 50% urea, depending on the type of tis- sue. These injections can produce a burning sen- sation (because urea is an acid), but injections of a local anesthetic can prevent this.
The usual oral dosage (for liver tumors) is 12 to 15 gm daily, given in divided doses. It can be placed in capsules or dissolved in juice. Danopoulos has given up to 30 gm daily in cases of very large liver tumors.
Note to researchers: It should not be difficult to carry out nutrition experiments, supplemented by ongoing microscopy examination, to see if the Erf-Miller thesis was correct.
Working Summary: The Erf-Miller theory does not solve all the problems, and was probably not accurate. Cancer cells are the result of inadequate nutrition and toxic wastes.
Drs. Erf and Miller of Jefferson Medical Col- lege and Hospital, Philadelphia, in an article in GP (the journal of the American Academy of Gen- eral Practice) for April 1957, set forth a new theory of the origin of cancer.
After considerable research work, they con- cluded that cancer cells are cells which have not matured. If the proper materials are present, every human cell will fully mature and do the function it is designed to do.
But if “maturant” substances are not pre- sent, these immature cells will continue to grow and divide—all the while remaining immature.
For example, in pernicious anemia, there are many immature red blood cells. Therefore, the pa- tient can die from a lack of mature red blood cells. Vitamin B12 solves the problem, enabling the cells to properly mature.
In leukemia and myeloma, two forms of can- cer, there is an abnormal production of immature red blood cells invading the bone marrow, liver, lymph, lungs, kidneys, etc. They take up room, but do not do what red blood cells are supposed to do.
These physicians wrote that, both in B12 defi- ciency and in cancer, under a microscope increas- ingly immature red blood cells are seen. They be- lieved that proper nutrition would enable all cells to mature properly.
____________________ LAWRENCE BURTON, Ph.D., 1959
Note to researchers: Burton developed, what he called, “immuno-Augmentive Therapy,” by injecting various blood prod- ucts into cancer patients to stimulate the immune system. Iso- lating the fractions of blood serum could be a special hurdle in seeking to replicate his work. But it should be attempted any- way. The interaction of tumor antibodies (IgG gamma globulin, plus related IgA and IgM proteins), with de-blocking factors (such as alpha-2-macroglobulin) and tumor complement, could pro- vide a needed breakthrough.
Working Summary: Burton’s formula is indeed intriguing. He claimed to only use four blood proteins to produce cancer remission. His clinic is still operating today in the Bahamas.
Born in the Bronx in 1926, Dr. Burton obtained a doctorate at New York University in 1955. In the mid-1950s, Burton and an associate